The MedTech Horizon: Exploring the Frontier of Cardiovascular Device Development in Heart Failure

Dean J. Kereiakes, MD, FACC, MSCAI, Vice-President, Medical Department, Medpace

Dr. Dean J. Kereiakes is Chairman and Medical Director of The Christ Hospital Heart and Vascular Institute, Medical Director of The Christ Hospital Research Institute and Professor of Clinical Medicine at The Ohio State University. At Medpace, Dr. Kereiakes serves as Medical Department Vice-President, providing hands-on medical leadership to sponsors and internal study teams engaged in cardiovascular clinical research.

He received his medical degree and was valedictorian of his graduating class at the University of Cincinnati in Ohio with postgraduate internship and residency at the University of California in San Francisco, senior residency at Massachusetts General Hospital in Boston and chief residency at the University of California. He completed fellowships in adult cardiology at the University of California and in coronary angioplasty at the San Francisco Heart Institute and the Sequoia Hospital.

Dr. Kereiakes has been a national/international Principal Investigator in trials for FDA approval of more than 26 novel drugs and medical devices. He founded and was Medical Director of The Carl & Edyth Lindner Center for Research and Education at The Christ Hospital, one of the top clinical research sites in the United States. Dr. Kereiakes has performed multiple First in Human and First in the US use of novel medical devices.

Dr. Kereiakes has published over 1200 peer-reviewed journal articles, abstracts and book chapters. He previously was Section Editor for Circulation and is currently Deputy Editor for the Journal of the Society for Coronary Angiography and Intervention (JSCAI).

Adam M. Lubert, MD, Medical Department, Medpace

Dr. Adam M. Lubert is an academic Cardiologist with board certifications in internal medicine, pediatrics, pediatric cardiology and adult congenital heart disease. At Medpace, he provides hands-on medical leadership to sponsors and internal study teams engaged in cardiovascular clinical research. He completed an internal medicine and pediatrics combined residency at the University of Cincinnati and cardiology training at the University of Michigan.

He served as an Adult Congenital Cardiologist on faculty at The University of Cincinnati and Cincinnati Children’s Hospital from 2018 to 2023. During that time, he started a heart failure clinic specializing in caring for a subset of patients with congenital heart failure. He has authored over 40 peer-reviewed publications and numerous book chapters across a broad range of cardiovascular conditions.

Aung Myat, MRCP, MD, FACC, FESC, Medical Department, Medpace

Dr. Aung Myat is a board-certified Interventional Cardiologist and Clinician Scientist. At Medpace, he provides hands-on medical leadership to sponsors and internal study teams engaged in cardiovascular clinical research. Dr. Myat has an established track record in clinical trial design, governance and execution, medical writing, retrospective and prospective large dataset analysis, education, training, mentorship and academic supervision.

He has over 20 years of medical experience working as a NHS Clinician and was, most recently, the leader of a multidisciplinary team delivering protocol-driven treatment in a Hospital Foundation Trust rated “Outstanding” by the Care Quality Commission.